Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paul

Showing results (711-720 of 763) with videos related to

Pageof 77
Sort By:
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Biological Psychiatry|June 24, 2023
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialG Paul Amminger, Simon Rice, Christopher G Davey, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Chemical Science|December 12, 2024
In search of herbistasis: COT-metsulfuron methyl displays rare herbistatic propertiesHui Xing, Sarah K M McGregor, Bruna D Batista, et al.
Frontiers in Psychiatry|June 30, 2020
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
JAMA Psychiatry|June 28, 2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized TrialPatrick D McGorry, Cristina Mei, G Paul Amminger, et al.
Schizophrenia Research|December 19, 2018
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trialLuke K Bolt, G Paul Amminger, John Farhall, et al.
Plos One|April 13, 2018
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICSNirupama Putcha, Gabriel G Paul, Antoine Azar, et al.
Early Intervention in Psychiatry|September 7, 2020
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosisAlison McLaverty, Kelly A Allott, Maximus Berger, et al.
Pageof 77

Showing results (711-720 of 763) with videos related to

Sort By:
Pageof 77
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Biological Psychiatry|June 24, 2023
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialG Paul Amminger, Simon Rice, Christopher G Davey, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Chemical Science|December 12, 2024
In search of herbistasis: COT-metsulfuron methyl displays rare herbistatic propertiesHui Xing, Sarah K M McGregor, Bruna D Batista, et al.
Frontiers in Psychiatry|June 30, 2020
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
JAMA Psychiatry|June 28, 2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized TrialPatrick D McGorry, Cristina Mei, G Paul Amminger, et al.
Schizophrenia Research|December 19, 2018
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trialLuke K Bolt, G Paul Amminger, John Farhall, et al.
Plos One|April 13, 2018
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICSNirupama Putcha, Gabriel G Paul, Antoine Azar, et al.
Early Intervention in Psychiatry|September 7, 2020
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosisAlison McLaverty, Kelly A Allott, Maximus Berger, et al.
Pageof 77